Figure 4

With BCG, our Biosafety level II surrogate for the M. tuberculosiscomplex, Monensin exhibits doses dependent inhibition.
With BCG, our Biosafety level II surrogate for the M. tuberculosiscomplex, Monensin exhibits doses dependent inhibition.